Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$820M |
| 2 |
Microsoft
MSFT
|
+$811M |
| 3 |
McDonald's
MCD
|
+$804M |
| 4 |
Coca-Cola
KO
|
+$655M |
| 5 |
Amazon
AMZN
|
+$646M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$1.64B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.1B |
| 3 |
Strategy Inc
MSTR
|
+$564M |
| 4 |
Kroger
KR
|
+$558M |
| 5 |
Danaher
DHR
|
+$494M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.33% |
| 2 | Healthcare | 3.23% |
| 3 | Consumer Discretionary | 2.55% |
| 4 | Financials | 2.55% |
| 5 | Industrials | 1.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11751
PUT
Lexicon Pharmaceuticals
LXRX
$1.03B
| $47.6K | ﹤0.01% |
50,300
-12,700
| -20% | -$8.23K |
|
11752
Caesarstone
CSTE
$119M
| $47.5K | ﹤0.01% |
24,115
+8,786
| +57% | +$19.9K |
|
11753
Edesa Biotech
EDSA
$51.5M
| $47.5K | ﹤0.01% |
23,514
+6,923
| +42% | +$14.7K |
|
11754
NeuroOne Medical Technologies
NMTC
$17.7M
| $47.5K | ﹤0.01% |
11,670
+9,985
| +593% | +$36.9K |
|
11755
Gogoro
GGR
$45.8M
| $47.1K | ﹤0.01% |
+8,269
| New | +$43K |
|
11756
SIMPPLE Ltd
SPPL
$23M
| $47.1K | ﹤0.01% |
+16,930
| New | +$54.8K |
|
|
LGO
11757
CALL
Largo
LGO
$74.1M
| $47.1K | ﹤0.01% |
36,200
+9,900
| +38% | +$13.9K |
|
|
STRR
11758
DELISTED
Star Equity Holdings
STRR
| $46.9K | ﹤0.01% |
+23,582
| New | +$50.1K |
|
|
ORGN
11759
DELISTED
Origin Materials
ORGN
| $46.7K | ﹤0.01% |
3,220
-5,568
| -63% | -$94.2K |
|
11760
CALL
Upland Software
UPLD
$15.7M
| $46.6K | ﹤0.01% |
2,390
-630
| -21% | -$14K |
|
|
IPHA
11761
Innate Pharma
IPHA
$205M
| $46.6K | ﹤0.01% |
26,617
+2,350
| +10% | +$4.77K |
|
11762
CALL
Anixa Biosciences
ANIX
$108M
| $46.5K | ﹤0.01% |
14,100
-10,400
| -42% | -$29.7K |
|
|
SY
11763
So-Young International
SY
$225M
| $46.5K | ﹤0.01% |
15,006
-57,253
| -79% | -$56.3K |
|
11764
PolyPid
PYPD
$90.9M
| $46.4K | ﹤0.01% |
13,151
+2,593
| +25% | +$7.59K |
|
11765
YieldMax MRNA Option Income Strategy ETF
MRNY
$117M
| $46.3K | ﹤0.01% |
+1,970
| New | +$48.5K |
|
|
AMOD
11766
Alpha Modus Holdings
AMOD
$21.9M
| $46.3K | ﹤0.01% |
1,015
-297
| -23% | -$14.8K |
|
11767
PUT
JELD-WEN Holding
JELD
$167M
| $46.3K | ﹤0.01% |
11,800
+4,400
| +59% | +$19.6K |
|
11768
Tandy Leather Factory
TLF
$21M
| $46.2K | ﹤0.01% |
14,894
-23,291
| -61% | -$68.7K |
|
|
APLT
11769
PUT
DELISTED
Applied Therapeutics
APLT
| $46.2K | ﹤0.01% |
148,400
-16,900
| -10% | -$6.54K |
|
11770
CALL
RLX Technology
RLX
$2.37B
| $46K | ﹤0.01% |
20,800
-15,200
| -42% | -$29.7K |
|
11771
Able View Global
ABLV
$33.8M
| $45.7K | ﹤0.01% |
43,977
+857
| +2% | +$958 |
|
11772
Infobird
IFBD
$8.68M
| $45.7K | ﹤0.01% |
40,806
+30,085
| +281% | +$34.1K |
|
|
AACG
11773
ATA Creativity
AACG
$41.5M
| $45.7K | ﹤0.01% |
59,282
+11,065
| +23% | +$9.93K |
|
|
SVC
11774
CALL
Service Properties Trust
SVC
$1.05B
| $45.6K | ﹤0.01% |
3,820
-480
| -11% | -$5.18K |
|
|
PN
11775
PN Smart Energy Ltd
PN
$36.7M
| $45.6K | ﹤0.01% |
+816
| New | +$44.8K |
|
Similar funds
Ken Griffin's Q2 2025 Portfolio in Review
As of Q2 2025, Ken Griffin held 15,819 positions worth $576B, up 9.2% from $527B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin withdrew a net $29.1B in Q2 2025, closing 3,524 positions and reducing 5,141 holdings. Its most notable exit was Kroger, an estimated $558M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.3% of assets, up from 2.9% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Walmart Inc worth $401M.
- Ken Griffin's largest Q2 2025 buy was Walmart Inc: 4,099,492 shares worth $401M.
- Ken Griffin added most to NVIDIA in Q2 2025, an estimated $820M increase.
- Ken Griffin's biggest Q2 2025 reduction was Charles Schwab, cutting an estimated $1.64B.
- Ken Griffin fully exited Kroger in Q2 2025, selling an estimated $558M.
- Ken Griffin's ten largest holdings make up 27% of its $576B portfolio in Q2 2025.
- Ken Griffin opened 1,459 new positions and closed 3,524 in Q2 2025.
- Ken Griffin's portfolio value rose 9.2% quarter-over-quarter to $576B.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.